Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter

Localized Transitional Cell Cancer of the Renal Pelvis and Ureter

Treatment of localized transitional cell cancer of the renal pelvis and ureter may include the following:

• Surgery (nephroureterectomy or segmental resection of ureter).
• A clinical trial of fulguration.
• A clinical trial of laser surgery.
• A clinical trial of segmental resection of the renal pelvis.
• A clinical trial of regional chemotherapy.
• A clinical trial of regional biologic therapy.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with localized transitional cell cancer of the renal pelvis and ureter.

Treatment of regional transitional cell cancer of the renal pelvis and ureter is usually done in a clinical trial. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with regional transitional cell cancer of the renal pelvis and ureter.

Treatment of metastatic transitional cell cancer of the renal pelvis and ureter is usually done in a clinical trial, which may include chemotherapy. Information about ongoing clinical trials is available from the NCI site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with metastatic transitional cell cancer of the renal pelvis and ureter.

Treatment of recurrent transitional cell cancer of the renal pelvis and ureter is usually done in a clinical trial, which may include chemotherapy. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent transitional cell cancer of the renal pelvis and ureter.

Back to Top

< Previous Section  |  Next Section >